Table 3 Maintenance Immunosuppression Therapy in de novo and Recurrent NASH
From: Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting
Immunosuppressant (± Mycophenolate) | De Novo NASH (n = 37) | Recurrent NASH (n = 19) | P value |
|---|---|---|---|
Tacrolimus | 21 (56.8%) | 14 (73.7%) | 0.2559 |
Cyclosporine | 4 (10.8%) | 2 (10.5%) | > 0.9999 |
Everolimus | 1 (2.7%) | 0 (0%) | > 0.9999 |
Sirolimus | 2 (5.4%) | 0 (0%) | 0.5435 |
Mycophenolate only | 6 (16.2%) | 3 (15.8%) | > 0.9999 |